Dermatology OTC Drugs Market Size, Share, Trends, Growth Outlook

The Global Dermatology OTC Drugs Market Size is estimated to register 5.1% growth over the forecast period from 2024 to 2030.

 

The market growth is driven by increasing Advances in dermatological research and technology drive the development of new and improved OTC drugs. Innovations in ingredients, formulations, and delivery systems enhance the effectiveness of dermatological products, attracting consumers looking for more advanced solutions to their skin concerns. Leading Companies focusing on Focus on Sustainable and Natural Ingredients, Customization and Personalization of Products, and others to boost market shares in the industry.

 

Dermatology OTC Drugs Market Overview

The dermatology Over-the-Counter (OTC) drugs market is experiencing notable growth driven by increasing consumer awareness, rising skin condition prevalence, technological advancements, and evolving consumer lifestyles. OTC products, addressing issues like acne and eczema, are sought after for their accessibility without prescription. The market sees a trend towards natural and organic ingredients, an e-commerce dominance, and a focus on customization. Challenges include regulatory complexities and heightened competition. Notably, advancements in dermatological research contribute to innovative formulations, reflecting a market shaped by a growing demand for effective, convenient, and personalized skincare solutions.

 

Dermatology OTC Drugs Market Dynamics

Market Trends- The growing emphasis on self-care through wellness-focused skincare is driving demand for over-the-counter dermatology products.

The growing focus on self-care in the realm of wellness-oriented skincare is driving an increased demand for over-the-counter (OTC) dermatology products. As individuals become more mindful of their overall well-being, skincare regimens are gaining significance as a vital aspect of self-care. This trend is marked by a shift towards preventive and holistic approaches to skincare, as consumers actively seek easily accessible solutions for common dermatological issues. The market is experiencing a surge in demand for OTC products tailored to address conditions like acne, aging, and sun damage. The heightened consumer awareness regarding the interconnection between skin health and overall well-being is fostering innovation in formulations, ingredients, and personalized skincare routines. Additionally, the convenience of acquiring OTC dermatology products without a prescription aligns with the changing preferences of consumers who are taking proactive control of their skincare practices as an integral part of their broader wellness journey.

 

Market Driver- The booming popularity of online sales and e-commerce platforms is fueling increased demand for over-the-counter dermatology drugs.

The rise in online sales and the widespread embrace of e-commerce platforms have significantly impacted the increased demand for over-the-counter (OTC) dermatology drugs. With consumers increasingly opting for digital channels for their shopping requirements, the convenience and accessibility provided by online platforms play a crucial role in fueling the popularity of skincare products. The simplicity of browsing, comparing, and purchasing OTC dermatology drugs online has redefined consumer habits, offering a convenient alternative to traditional brick-and-mortar pharmacies. This shift in buying preferences aligns with broader trends in the retail sector, highlighting the significance of a seamless online shopping experience. Consequently, pharmaceutical and skincare companies are strategically utilizing e-commerce channels to expand their reach, capitalize on emerging market trends, and cater to the evolving needs of consumers seeking effective dermatological solutions in the digital era.

 

Market Opportunity- Dermatological OTC treatments are getting a revamp with cutting-edge ingredients and advanced formulation techniques

The landscape of dermatological over-the-counter (OTC) treatments is experiencing a profound evolution through the integration of state-of-the-art ingredients and advanced formulation methods. Skincare innovations are reshaping how OTC products tackle diverse dermatological conditions. Companies are progressively incorporating unique and technologically advanced elements, such as peptides, antioxidants, and microbiome-friendly components, to augment the effectiveness of their formulations. These ingredients are specifically chosen for their capacity to address particular skin concerns, stimulate collagen production, and offer antioxidant benefits. Employing advanced formulation techniques like nanotechnology and encapsulation enhances the delivery of active ingredients, ensuring improved penetration and efficacy. Consequently, consumers now have access to OTC treatments that not only prioritize convenience but also provide cutting-edge solutions for a broad spectrum of skin issues, ushering in a more sophisticated and personalized approach to skincare.

 

Market Share Analysis- Psoriasis Dermatology OTC Drugs Market will register the fastest growth

The Global Dermatology OTC Drugs Market is analyzed across Acne, Dermatitis, Psoriasis, Fungal Infections, and others. Psoriasis is poised to register the fastest growth. The Psoriasis Dermatology Over-the-Counter (OTC) Drugs Market is expanding due to the rising global prevalence of psoriasis. This market primarily offers accessible topical treatments, including corticosteroids, coal tar products, and moisturizers, aiming to alleviate symptoms and improve skin conditions. Increased consumer awareness about psoriasis has contributed to the growing demand for OTC solutions. Regulatory considerations, ongoing advancements in formulations, and the trend of online sales are shaping the landscape of OTC drugs for psoriasis, emphasizing the need for effective and convenient options to manage psoriasis symptoms without a prescription.

 

Market Share Analysis- Oils, Gels, Creams, and Ointments held a significant market share in 2024

The Global Dermatology OTC Drugs Market is analyzed across various Organizations including Tablets and Capsules, Oils, Gels, Creams, Ointments, and others. Of these, Oils, Gels, Creams, and Ointments held a significant market share in 2024. The Dermatology Over-the-Counter (OTC) Drugs Market includes a variety of topical formulations, namely oils, gels, creams, and ointments, designed for self-administration without a prescription. Oils provide hydration and nourishment, gels are lightweight and water-based, creams offer versatility for different skin types, and ointments are preferred for dry or damaged skin. This dynamic market is shaped by consumer preferences, innovations in ingredients, and the trend toward personalized skincare solutions, providing a diverse range of choices to address specific dermatological concerns.

 

Dermatology OTC Drugs Market Segmentation

By Indication

• Acne
• Dermatitis
• Psoriasis
• Fungal Infections
• Others

 

 By Product

• Tablets and Capsules
• Oils, Gels, Creams, and Ointments
• Others

 

 By Route of Administration

• Oral
• Topical

 

By Distribution Channel

• Hospital and Retail Pharmacies
• Online Pharmacies
• Others

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

Dermatology OTC Drugs Market Companies

• Perrigo Company plc
• Bausch Health Companies Inc.
• Dr. Reddy's Laboratories
• Johnson and Johnson
• Bayer AG
• GlaxoSmithKline plc.
• Viatris Inc
• LEO Pharma A/S
• Acella Pharmaceuticals, LLC
• Teva Pharmaceutical Industries Ltd.
• Galderma

 

*List not exhaustive

Dermatology OTC Drugs Market Outlook 2024

1 Market Overview

1.1 Introduction to the Dermatology OTC Drugs Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2024 Dermatology OTC Drugs Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Dermatology OTC Drugs Market Companies with Area Served

4.2.2 Products Offerings Global Dermatology OTC Drugs Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 post-COVID-19 Scenario- Low Growth Case

5.1.3 post-COVID-19 Scenario- Reference Growth Case

5.1.4 post-COVID-19 Scenario- Low Growth Case

 

6 Global Dermatology OTC Drugs Market Trends

6.1 Global Dermatology OTC Drugs Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Dermatology OTC Drugs Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Dermatology OTC Drugs Revenue (USD Million) and CAGR (%) by regions (2018-2030)

 

7 Global Dermatology OTC Drugs Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Dermatology OTC Drugs Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Dermatology OTC Drugs Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Dermatology OTC Drugs Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Dermatology OTC Drugs Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Dermatology OTC Drugs Development Regional Status and Outlook

8.1 Global Dermatology OTC Drugs Revenue (USD Million) By Regions (2018-2022)

8.2 North America Dermatology OTC Drugs Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Dermatology OTC Drugs Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Dermatology OTC Drugs Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Dermatology OTC Drugs Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Dermatology OTC Drugs Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Dermatology OTC Drugs Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Dermatology OTC Drugs Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Dermatology OTC Drugs Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Dermatology OTC Drugs Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) by Applications (2018-2022)

8.5 South America Dermatology OTC Drugs Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Dermatology OTC Drugs Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Dermatology OTC Drugs Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Dermatology OTC Drugs Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Dermatology OTC Drugs Market Revenue (USD Million), by Type, and Applications (2024-2030)

10.1 Global Dermatology OTC Drugs Revenue (USD Million) and Market Share (%) by Type (2024-2030)

10.1.1 Global Dermatology OTC Drugs Revenue (USD Million), and Market Share (%) by Type (2024-2030)

10.2 Global Dermatology OTC Drugs Revenue (USD Million) and Market Share (%) by Applications (2024-2030)

10.2.1 Global Dermatology OTC Drugs Revenue (USD Million), and Market Share (%) by Applications (2024-2030)

 

11 Global Dermatology OTC Drugs Development Regional Status and Outlook Forecast

11.1 Global Dermatology OTC Drugs Revenue (USD Million) By Regions (2024-2030)

11.2 North America Dermatology OTC Drugs Revenue (USD Million) by Type, and Applications (2024-2030)

11.2.1 North America Dermatology OTC Drugs Revenue (USD) Million by Country (2024-2030)

11.2.2 North America Dermatology OTC Drugs Revenue (USD Million), by Type (2024-2030)

11.2.3 North America Dermatology OTC Drugs Revenue (USD Million), Market Share (%) by Applications (2024-2030)

11.3 Europe Dermatology OTC Drugs Revenue (USD Million), by Type, and Applications (2024-2030)

11.3.1 Europe Dermatology OTC Drugs Revenue (USD Million), by Country (2024-2030)

11.3.2 Europe Dermatology OTC Drugs Revenue (USD Million), by Type (2024-2030)

11.3.3 Europe Dermatology OTC Drugs Revenue (USD Million), by Applications (2024-2030)

11.4 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) by Type, and Applications (2024-2030)

11.4.1 Asia Pacific Dermatology OTC Drugs Revenue (USD Million), by Country (2024-2030)

11.4.2 Asia Pacific Dermatology OTC Drugs Revenue (USD Million), by Type (2024-2030)

11.4.3 Asia Pacific Dermatology OTC Drugs Revenue (USD Million), by Applications (2024-2030)

11.5 South America Dermatology OTC Drugs Revenue (USD Million), by Type, and Applications (2024-2030)

11.5.1 South America Dermatology OTC Drugs Revenue (USD Million), by Country (2024-2030)

11.5.2 South America Dermatology OTC Drugs Revenue (USD Million), by Type (2024-2030)

11.5.3 South America Dermatology OTC Drugs Revenue (USD Million), by Applications (2024-2030)

11.6 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million), by Type, and Applications (2024-2030)

11.6.1 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million), by region (2024-2030)

11.6.2 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million), by Type (2024-2030)

11.6.3 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million), by Applications (2024-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Dermatology OTC Drugs Market Companies with Areas Served

Table 3 Products Offerings Global Dermatology OTC Drugs Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Dermatology OTC Drugs Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Dermatology OTC Drugs Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Dermatology OTC Drugs Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Dermatology OTC Drugs Revenue (USD Million) By Type (2018-2022)

Table 11 Global Dermatology OTC Drugs Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Dermatology OTC Drugs Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Dermatology OTC Drugs Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Dermatology OTC Drugs Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Dermatology OTC Drugs Market Share (%) By Regions (2018-2022)

Table 16 North America Dermatology OTC Drugs Revenue (USD Million) By Country (2018-2022)

Table 17 North America Dermatology OTC Drugs Revenue (USD Million) By Type (2018-2022)

Table 18 North America Dermatology OTC Drugs Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Dermatology OTC Drugs Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Dermatology OTC Drugs Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Dermatology OTC Drugs Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Dermatology OTC Drugs Revenue (USD Million) By Country (2018-2022)

Table 26 South America Dermatology OTC Drugs Revenue (USD Million) By Type (2018-2022)

Table 27 South America Dermatology OTC Drugs Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Dermatology OTC Drugs Revenue (USD Million) By Type (2024-2030)

Table 33 Global Dermatology OTC Drugs Revenue Market Share (%) By Type (2024-2030)

Table 34 Global Dermatology OTC Drugs Revenue (USD Million) By Applications (2024-2030)

Table 35 Global Dermatology OTC Drugs Revenue Market Share (%) By Applications (2024-2030)

Table 36 Global Dermatology OTC Drugs Market Revenue (USD Million), And Revenue (USD Million) By Regions (2024-2030)

Table 37 North America Dermatology OTC Drugs Revenue (USD)By Country (2024-2030)

Table 38 North America Dermatology OTC Drugs Revenue (USD Million) By Type (2024-2030)

Table 39 North America Dermatology OTC Drugs Revenue (USD Million) By Applications (2024-2030)

Table 40 Europe Dermatology OTC Drugs Revenue (USD Million) By Country (2024-2030)

Table 41 Europe Dermatology OTC Drugs Revenue (USD Million) By Type (2024-2030)

Table 42 Europe Dermatology OTC Drugs Revenue (USD Million) By Applications (2024-2030)

Table 43 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) By Country (2024-2030)

Table 44 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) By Type (2024-2030)

Table 45 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) By Applications (2024-2030)

Table 46 South America Dermatology OTC Drugs Revenue (USD Million) By Country (2024-2030)

Table 47 South America Dermatology OTC Drugs Revenue (USD Million) By Type (2024-2030)

Table 48 South America Dermatology OTC Drugs Revenue (USD Million) By Applications (2024-2030)

Table 49 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Region (2024-2030)

Table 50 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Region (2024-2030)

Table 51 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Type (2024-2030)

Table 52 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Applications (2024-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Dermatology OTC Drugs Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Dermatology OTC Drugs Revenue Market Share (%) By Type (2022)

Figure 5 Global Dermatology OTC Drugs Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Dermatology OTC Drugs Revenue Market Share (%) By Applications (2022)

Figure 7 Global Dermatology OTC Drugs Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Dermatology OTC Drugs Market Share (%) By Regions (2022)

Figure 9 North America Dermatology OTC Drugs Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Dermatology OTC Drugs Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Dermatology OTC Drugs Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Dermatology OTC Drugs Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Dermatology OTC Drugs Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Dermatology OTC Drugs Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Dermatology OTC Drugs Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Dermatology OTC Drugs Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Dermatology OTC Drugs Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Dermatology OTC Drugs Revenue (USD Million) By Type (2024-2030)

Figure 25 Global Dermatology OTC Drugs Revenue Market Share (%) By Type (2030)

Figure 26 Global Dermatology OTC Drugs Revenue (USD Million) By Applications (2024-2030)

Figure 27 Global Dermatology OTC Drugs Revenue Market Share (%) By Applications (2030)

Figure 28 Global Dermatology OTC Drugs Market Revenue (USD Million) By Regions (2024-2030)

Figure 29 North America Dermatology OTC Drugs Revenue (USD Million) By Country (2024-2030)

Figure 30 North America Dermatology OTC Drugs Revenue (USD Million) By Type (2024-2030)

Figure 31 North America Dermatology OTC Drugs Revenue (USD Million) By Applications (2024-2030)

Figure 32 Europe Dermatology OTC Drugs Revenue (USD Million) By Country (2024-2030)

Figure 33 Europe Dermatology OTC Drugs Revenue (USD Million) By Type (2024-2030)

Figure 34 Europe Dermatology OTC Drugs Revenue (USD Million) By Applications (2024-2030)

Figure 35 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) By Country (2024-2030)

Figure 36 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) By Type (2024-2030)

Figure 37 Asia Pacific Dermatology OTC Drugs Revenue (USD Million) By Applications (2024-2030)

Figure 38 South America Dermatology OTC Drugs Revenue (USD Million) By Country (2024-2030)

Figure 39 South America Dermatology OTC Drugs Revenue (USD Million) By Type (2024-2030)

Figure 40 South America Dermatology OTC Drugs Revenue (USD Million) By Applications (2024-2030)

Figure 41 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Region (2024-2030)

Figure 42 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Region (2024-2030)

Figure 43 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Type (2024-2030)

Figure 44 Middle East and Africa Dermatology OTC Drugs Revenue (USD Million) By Applications (2024-2030)

Figure 45 Bottom-Up and Top-Down Approaches for This Report

Figure 46 Data Triangulation

 

Dermatology OTC Drugs Market Segmentation

By Indication

• Acne
• Dermatitis
• Psoriasis
• Fungal Infections
• Others

 

 By Product

• Tablets and Capsules
• Oils, Gels, Creams, and Ointments
• Others

 

 By Route of Administration

• Oral
• Topical

 

By Distribution Channel

• Hospital and Retail Pharmacies
• Online Pharmacies
• Others

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)